AstraZeneca and Daiichi Sankyo Secure Groundbreaking Lung Cancer Approval for Datroway
AstraZeneca and Daiichi Sankyo have achieved a significant milestone by securing FDA approval for Da
Back To Top
State-of-the-art data science and AI power quant models, valuation, sentiment, and volatility analysis. Serious tools built for serious decisions.
AstraZeneca and Daiichi Sankyo have achieved a significant milestone by securing FDA approval for Da
Federal Reserve Chair Jerome Powell recently made critical statements during his testimony before th
Alibaba’s stock surged, climbing 2.1% to HK$113.10 after news emerged that the company will in
In his latest address, Federal Reserve Chair Jerome Powell discussed the potential impact of tariffs
JPMorgan has launched coverage of AO Smith with a Neutral rating and a price target set at $70, reco
As we approach the end of June 2025, investors must keep a sharp eye on the real estate market. Thre
Morgan Stanley has started coverage on Amrize Ltd with an Overweight rating and a price target of $6
Wall Street seems to be riding a wave of optimism this Tuesday. Dow Futures experienced a significan
Asian stock markets experienced a significant uptick, led by South Korea’s KOSPI and Hong Kong’s
Cryptocurrency markets have taken a downturn today. Traders are quickly taking profits after recent rallies. Key price points include Bitcoin at $115040.35, Ethereum valued at
The NZD/USD pair begins the week strong, comfortably staying above the 0.5900 mark during the Asian session. While the positive sentiment is beneficial for the
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) grapples with a concerning financial state, showcasing a Return on Invested Capital (ROIC) of -72.78% and a Weighted Average Cost of
This past week, the S&P 500 (SPX) reached three new record highs, influenced primarily by inflation news impacting stock prices significantly.
Dogecoin is testing important support near $0.22. Experts believe this level is critical for a potential turnaround. Market watchers are particularly focused on the $0.20
The People’s Bank of China (PBOC) has set the USD/CNY central rate at 7.1322 for the trading session. This adjustment comes compared to the prior
Minerva Neurosciences, Inc. (NASDAQ:NERV) demonstrates promising growth potential of approximately 25.35% driven by its lead candidate, roluperidone aimed at treating schizophrenia. Reviva Pharmaceuticals Holdings, Inc.
Jeremy Siegel, Wharton School’s finance professor, shares his insights on the economy’s state, tariff impacts, and the Fed’s inflation control measures.
